230 related articles for article (PubMed ID: 2298269)
1. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
[TBL] [Abstract][Full Text] [Related]
2. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
[TBL] [Abstract][Full Text] [Related]
3. Elimination of malignant clonogenic cells from human bone marrow using multiple myeloid cell-specific monoclonal antibodies and complement.
Hu ZB; Yu ZF; Qiao CN; Ma WL
Chin Med J (Engl); 1991 Aug; 104(8):664-8. PubMed ID: 1914634
[TBL] [Abstract][Full Text] [Related]
4. Immunomagnetic bone marrow purging of common acute lymphoblastic leukemia cells: suitability of BioMag particles.
Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR
Bone Marrow Transplant; 1991 Mar; 7(3):199-203. PubMed ID: 2059757
[TBL] [Abstract][Full Text] [Related]
5. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
6. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
8. Photoradiation methods for purging autologous bone marrow grafts.
Gulati S; Atzpodien J; Lemoli RM; Shimazaki C; Clarkson B
Prog Clin Biol Res; 1990; 333():87-102. PubMed ID: 2137934
[TBL] [Abstract][Full Text] [Related]
9. Selective depletion of human myeloma clonogenic stem cells from bone marrow cell preparations by a plasma-cell reactive antibody and complement.
Stone MJ; Tong AW; Fay JW; Lee JC
Cancer Detect Prev; 1988; 12(1-6):621-35. PubMed ID: 3180147
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow transplantation for B cell malignancies after in vitro purging with floating immunobeads.
Stoppa AM; Hirn J; Blaise D; Delaage M; Novakovitch G; Viens P; Capiello MA; Mannoni P; Mawas C; Maraninchi D
Bone Marrow Transplant; 1990 Nov; 6(5):301-7. PubMed ID: 2291992
[TBL] [Abstract][Full Text] [Related]
12. Complement depletion in vitro limits monoclonal antibody 6-19-dependent complement-mediated killing of tumor cells in bone marrow.
Duerst RE; Rose D; Frantz CN
Exp Hematol; 1991 Oct; 19(9):863-7. PubMed ID: 1893961
[TBL] [Abstract][Full Text] [Related]
13. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
Gidáli J; Fehér I; Kovács P
Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
[TBL] [Abstract][Full Text] [Related]
14. Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells.
Howell AL; Fogg-Leach M; Davis BH; Ball ED
Bone Marrow Transplant; 1989 May; 4(3):317-22. PubMed ID: 2659117
[TBL] [Abstract][Full Text] [Related]
15. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
[TBL] [Abstract][Full Text] [Related]
16. Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies.
De Rosa L; Montuoro A; Pandolfi A; Lanti T; Pescador L; Morara R; De Laurenzi A
Haematologica; 1991 Mar; 76 Suppl 1():37-40. PubMed ID: 1864552
[TBL] [Abstract][Full Text] [Related]
17. Malignant leukemic cell separation by iron colloid immunomagnetic adsorption.
Biéva CJ; Vander Brugghen FJ; Stryckmans PA
Exp Hematol; 1989 Sep; 17(8):914-20. PubMed ID: 2670597
[TBL] [Abstract][Full Text] [Related]
18. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
[TBL] [Abstract][Full Text] [Related]
19. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
Lagneaux L; Marie JP; Delforge A; Socquet M; Thevenin D; Zittoun R; Stryckmans P
Exp Hematol; 1989 Aug; 17(7):843-6. PubMed ID: 2753092
[TBL] [Abstract][Full Text] [Related]
20. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
Bast RC; De Fabritiis P; Lipton J; Gelber R; Maver C; Nadler L; Sallan S; Ritz J
Cancer Res; 1985 Feb; 45(2):499-503. PubMed ID: 3967224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]